Samil Pharm Cash Flow Conversion Efficiency

Latest as of June 2025: 0.016x

Samil Pharm cash flow conversion efficiency. Based on the latest financial reports, Samil Pharm (000520) has a cash flow conversion efficiency ratio of 0.016x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.44 Billion ≈ $1.66 Million USD) by net assets (₩149.26 Billion ≈ $101.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Samil Pharm (2012–2024)

Cash flow conversion efficiency of Samil Pharm from 2012 to 2024. This chart illustrates how Samil Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Samil Pharm stock price today for real-time trading data and today's change.

Samil Pharm Cash Flow Conversion Ratio Explained

Samil Pharm cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Samil Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Samil Pharm ranked by their cash flow conversion efficiency. Also see 000520 market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
O-TA Precision Industry Co Ltd TWO:8924	0.031x
Lastminute.com NV SW:LMN	1.485x
Davicom Semiconductor Inc TW:3094	0.005x
WCT Holdings Bhd KLSE:9679	-0.027x
Immunic Inc NASDAQ:IMUX	2.889x
DaeChang Solution Co. Ltd KQ:096350	-0.002x
Rupa & Company Limited NSE:RUPA	0.023x
Thien Viet Securities JSC VN:TVS	-0.388x

Annual Cash Flow Conversion Efficiency for Samil Pharm (2012–2024)

The table below shows the annual cash flow conversion efficiency of Samil Pharm from 2012 to 2024. Review 000520 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩176.12 Billion ≈ $119.36 Million	₩2.59 Billion ≈ $1.76 Million	0.015x	-84.00%
2023-12-31	₩127.83 Billion ≈ $86.63 Million	₩11.75 Billion ≈ $7.96 Million	0.092x	+178.32%
2022-12-31	₩125.82 Billion ≈ $85.27 Million	₩4.15 Billion ≈ $2.82 Million	0.033x	+53.20%
2021-12-31	₩65.75 Billion ≈ $44.56 Million	₩1.42 Billion ≈ $960.19K	0.022x	-82.38%
2020-12-31	₩63.55 Billion ≈ $43.07 Million	₩7.77 Billion ≈ $5.27 Million	0.122x	-28.06%
2019-12-31	₩62.27 Billion ≈ $42.20 Million	₩10.59 Billion ≈ $7.18 Million	0.170x	+463.81%
2018-12-31	₩56.08 Billion ≈ $38.01 Million	₩-2.62 Billion ≈ $-1.78 Million	-0.047x	-163.08%
2017-12-31	₩51.17 Billion ≈ $34.68 Million	₩3.79 Billion ≈ $2.57 Million	0.074x	-30.47%
2016-12-31	₩52.87 Billion ≈ $35.83 Million	₩5.63 Billion ≈ $3.82 Million	0.107x	+98.58%
2015-12-31	₩54.41 Billion ≈ $36.87 Million	₩2.92 Billion ≈ $1.98 Million	0.054x	+124.94%
2014-12-31	₩55.42 Billion ≈ $37.55 Million	₩-11.92 Billion ≈ $-8.08 Million	-0.215x	-277.61%
2013-12-31	₩70.03 Billion ≈ $47.46 Million	₩-3.99 Billion ≈ $-2.70 Million	-0.057x	-171.32%
2012-12-31	₩62.87 Billion ≈ $42.61 Million	₩5.02 Billion ≈ $3.40 Million	0.080x	--

About Samil Pharm

KO:000520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$105.60 Million

₩155.83 Billion KRW

Market Cap Rank

#18744 Global

#852 in Korea

Share Price

₩7340.00

Change (1 day)

-5.66%

52-Week Range

₩5830.00 - ₩12310.00

All Time High

₩23603.13